SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-023658
Filing Date
2022-08-22
Accepted
2022-08-22 08:30:55
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2006030
2 ex31-1.htm EX-31.1 20081
3 ex31-2.htm EX-31.2 20244
4 ex32-1.htm EX-32.1 6734
5 ex32-2.htm EX-32.2 6532
  Complete submission text file 0001493152-22-023658.txt   9266479

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20220630.xsd EX-101.SCH 65284
7 XBRL CALCULATION FILE otlc-20220630_cal.xml EX-101.CAL 49120
8 XBRL DEFINITION FILE otlc-20220630_def.xml EX-101.DEF 321950
9 XBRL LABEL FILE otlc-20220630_lab.xml EX-101.LAB 480284
10 XBRL PRESENTATION FILE otlc-20220630_pre.xml EX-101.PRE 410169
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1738098
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 221182279
SIC: 2834 Pharmaceutical Preparations